Nektar Therapeutics Share Price
NASDAQ: NKTR | Small CapNektar Therapeutics Stock Performance
Nektar Therapeutics Share Price Today
As of 31 October 2026, Nektar Therapeutics's share price is $38.88. The stock opened at $39.02, compared to its previous close of $39.25. During today's trading session, Nektar Therapeutics's share price traded between $38.00 and $39.02, with an average price of $38.51. Over the past 52 weeks, the stock has recorded a high of $108.83 and a low of $33.58. In terms of performance, Nektar Therapeutics's share price has declined by 54.31% over the last six months and is down 40.10% on a year-on-year basis.
Nektar Therapeutics Share Price Chart
Nektar Therapeutics Quarterly Profit & Loss
All figures in USD
Nektar Therapeutics Annual Profit & Loss
All figures in USD
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Nektar Therapeutics Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $55.45 | $38.88 | -35.92% |
Sep 2026 | $72.06 | $60.67 | -18.59% |
Aug 2026 | $69.28 | $74.53 | +5.43% |
Jul 2026 | $68.80 | $70.69 | +1.33% |
Jun 2026 | $64.50 | $69.76 | +7.62% |
May 2026 | $85.00 | $64.82 | -23.81% |
Apr 2026 | $72.59 | $85.08 | +18.31% |
Mar 2026 | $68.56 | $71.92 | +4.33% |
Feb 2026 | $38.18 | $68.93 | +84.55% |
Jan 2026 | $42.62 | $37.35 | -11.61% |
Dec 2025 | $64.31 | $42.26 | -35.08% |
Nov 2025 | $62.41 | $65.09 | +0.29% |